Method for preparing adenovirus vector vaccine through perfusion culture process
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- CANSINO BIOLOGICS INC
- Publication Date
- 2020-12-18
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of biological products, in particular to a method for culturing an adenovirus host cell, a method for producing an adenovirus and a method for preparing an adenovirus vector vaccine, in particular to a method for preparing an adenovirus vector vaccine through a perfusion culture process. Background technique
[0002] Adenovirus is a non-enveloped DNA virus, which has the characteristics of easy infection, wide host range, low toxicity, safe use, large capacity, non-integration, low pathogenicity to humans, and no induction of cancer. Become one of the most promising gene carriers in gene transfer.
[0003] The modified adenovirus removes the E1 / E3 gene expression cassette, prevents the transcription of functional proteins dependent on the E1 region and the E3 region, and the subsequent replication of viral DNA and the production of viral coat proteins. The E1 / E3-deleted adenovirus can provide E1 / E3 region ...